Bancha Satirapoj

2.8k total citations
104 papers, 1.6k citations indexed

About

Bancha Satirapoj is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Bancha Satirapoj has authored 104 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Nephrology, 29 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Surgery. Recurrent topics in Bancha Satirapoj's work include Chronic Kidney Disease and Diabetes (33 papers), Dialysis and Renal Disease Management (31 papers) and Diabetes Treatment and Management (17 papers). Bancha Satirapoj is often cited by papers focused on Chronic Kidney Disease and Diabetes (33 papers), Dialysis and Renal Disease Management (31 papers) and Diabetes Treatment and Management (17 papers). Bancha Satirapoj collaborates with scholars based in Thailand, United States and Japan. Bancha Satirapoj's co-authors include Ouppatham Supasyndh, Sharon G. Adler, Amnart Chaiprasert, Cynthia C. Nast, Chagriya Kitiyakara, Pornanong Aramwit, Piyanuch Radinahamed, Tiane Dai, Janine LaPage and Yingyos Avihingsanon and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Bancha Satirapoj

97 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bancha Satirapoj Thailand 24 745 379 257 228 227 104 1.6k
Ki Ryang Na South Korea 22 708 1.0× 237 0.6× 310 1.2× 325 1.4× 232 1.0× 110 1.6k
Kyung Hwan Jeong South Korea 22 703 0.9× 212 0.6× 445 1.7× 368 1.6× 151 0.7× 129 1.7k
Sang Heon Song South Korea 22 826 1.1× 301 0.8× 390 1.5× 284 1.2× 265 1.2× 158 1.9k
Ole Torffvit Sweden 30 710 1.0× 584 1.5× 318 1.2× 235 1.0× 332 1.5× 96 2.1k
Sung Gyun Kim South Korea 22 899 1.2× 136 0.4× 268 1.0× 256 1.1× 237 1.0× 128 1.9k
James Ehrlich United States 17 704 0.9× 489 1.3× 162 0.6× 324 1.4× 552 2.4× 23 2.0k
Kausik Umanath United States 14 655 0.9× 298 0.8× 301 1.2× 193 0.8× 164 0.7× 27 1.4k
Robert Ekart Slovenia 24 925 1.2× 366 1.0× 210 0.8× 470 2.1× 489 2.2× 121 2.1k
Hiroki Adachi Japan 16 414 0.6× 335 0.9× 293 1.1× 210 0.9× 83 0.4× 74 1.1k
Mari-Anne Gall Denmark 17 667 0.9× 797 2.1× 253 1.0× 304 1.3× 725 3.2× 26 2.1k

Countries citing papers authored by Bancha Satirapoj

Since Specialization
Citations

This map shows the geographic impact of Bancha Satirapoj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bancha Satirapoj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bancha Satirapoj more than expected).

Fields of papers citing papers by Bancha Satirapoj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bancha Satirapoj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bancha Satirapoj. The network helps show where Bancha Satirapoj may publish in the future.

Co-authorship network of co-authors of Bancha Satirapoj

This figure shows the co-authorship network connecting the top 25 collaborators of Bancha Satirapoj. A scholar is included among the top collaborators of Bancha Satirapoj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bancha Satirapoj. Bancha Satirapoj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Supasyndh, Ouppatham, et al.. (2024). Risk factors associated with mortality among patients on maintenance hemodialysis: The Thailand Renal Replacement Therapy registry. Therapeutic Apheresis and Dialysis. 28(6). 839–854. 2 indexed citations
3.
Chattranukulchai, Pairoj, Weranuj Roubsanthisuk, Praew Kotruchin, et al.. (2024). Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society. Hypertension Research. 47(9). 2447–2455. 2 indexed citations
4.
Satirapoj, Bancha, et al.. (2024). Intradialytic oral nutrition effects on malnourished hemodialysis patients: a randomized trial. Scientific Reports. 14(1). 21400–21400. 2 indexed citations
5.
Saxena, Amit, Ellen M. Ginzler, Keisha L. Gibson, et al.. (2023). Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & Rheumatology. 76(1). 59–67. 49 indexed citations
6.
Chaiprasert, Amnart, et al.. (2023). Effect of intradialytic weight resistance training exercise in sarcopenic hemodialysis patients: A randomized controlled trial. Therapeutic Apheresis and Dialysis. 28(2). 182–191. 1 indexed citations
7.
Chaiprasert, Amnart, et al.. (2022). Amelioration of Uremic Toxin Indoxyl Sulfate by Oral Chito-Oligosaccharide in Predialysis Patients: A Randomized Controlled Trial. Journal of the American Society of Nephrology. 33(11S). 852–852. 1 indexed citations
10.
Supasyndh, Ouppatham, et al.. (2021). Ankle-brachial index predicts renal outcomes and all-cause mortality in high cardiovascular risk population: a nationwide prospective cohort study in CORE project. International Urology and Nephrology. 54(7). 1641–1652. 1 indexed citations
12.
Satirapoj, Bancha, et al.. (2021). Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial. BMC Nephrology. 22(1). 236–236. 15 indexed citations
14.
Supasyndh, Ouppatham, et al.. (2020). Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria. Journal of Diabetes Research. 2020. 1–6. 9 indexed citations
16.
Kaewput, Wisit, et al.. (2016). Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study. International Journal of Nephrology and Renovascular Disease. Volume 9. 273–278. 5 indexed citations
17.
Satirapoj, Bancha, et al.. (2015). The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease. International Journal of Nephrology. 2015. 1–6. 7 indexed citations
18.
Satirapoj, Bancha, Cynthia C. Nast, & Sharon G. Adler. (2012). Novel Insights into the Relationship Between Glomerular Pathology and Progressive Kidney Disease. Advances in Chronic Kidney Disease. 19(2). 93–100. 34 indexed citations
19.
Satirapoj, Bancha, et al.. (2011). Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population.. PubMed. 42(1). 176–83. 12 indexed citations
20.
Satirapoj, Bancha, Ying Wang, Tiane Dai, et al.. (2011). Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrology Dialysis Transplantation. 27(7). 2702–2711. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026